NASDAQ: NGNE 31.15%
Neurogene Shares Rally on FDA Breakthrough Therapy Designation for Rett Syndrome Therapy
NASDAQ: DLLL 42.51%
US Companies Moving the Markets, Evening edition Fri, Feb 27, 2026 as of 4:00 pm ET
NYSE: BATL 21.08%
Halftime Market Summary: Stocks to Watch before Super Bowl Weekend
OTC: ACXIF 21.95%
Underperform Recommendation Issued On ACXIF By RBC Capital
NASDAQ: EDSA 47.03%
$38M Defense Backlog vs. $6M Market Cap, Breakthrough Biotech Data, and the Quantum Security Land Grab
NASDAQ: PSKY 24.52%
Warner Bros Discovery Deal: Why Netflix May Have Still Won
NASDAQ: NGNE 42.51%
NASDAQ: BATL 42.51%
NASDAQ: ACXIF 42.51%
NASDAQ: EDSA 42.51%
